![Brain Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 487 216 $ al 30/09/2026
Dr. Brain K.
Roberts, MD, is a Chief Medical Officer at Rezolute, Inc. Dr. Roberts was previously employed as a Senior Director by FibroGen, Inc. He received his undergraduate degree from the University of California San Diego and a doctorate degree from Georgetown University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REZOLUTE, INC. 0,12 % | 21/09/2026 | 117.685 ( 0,12 % ) | 487 216 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REZOLUTE, INC. | Director Técnico/Científico/I+D | 01/06/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Director/Miembro de la Junta | 01/04/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
